You are here: Home: CACU 2 | 2008: Faculty Disclosures

CONTENT VALIDATION AND DISCLOSURES

Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities. Real or apparent conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.

FACULTY Dr Winer had no real or apparent conflicts of interest to disclose. The following faculty (and their spouses/partners) reported real or apparent conflicts of interest, which have been resolved through a conflict of interest resolution process: Dr GeorgeAdvisory Committee: Pfizer Inc, Sanofi-Aventis, Wyeth; Consulting Agreements: Genentech BioOncology, GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Pfizer Inc, Sanofi-Aventis, Wyeth; Paid Research: Amgen Inc, Bristol-Myers Squibb Company, GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Pfizer Inc, Wyeth; Speakers Bureau: Pfizer Inc, Sanofi-Aventis. Dr KimAdvisory Committee: AstraZeneca Pharmaceuticals LP, ImClone Systems Incorporated; Paid Research: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Genentech BioOncology, ImClone Systems Incorporated, OSI Pharmaceuticals Inc, Sanofi- Aventis; Speakers Bureau: Eli Lilly and Company, Genentech BioOncology, Sanofi-Aventis. Dr LeonardAdvisory Committee: Celgene Corporation, Cephalon Inc, Millennium Pharmaceuticals, The Takeda Oncology Company, Novartis Pharmaceuticals Corporation, Pharmion Corporation, Wyeth; Consulting Agreements: Biogen Idec, Genentech BioOncology, GlaxoSmithKline, Millennium Pharmaceuticals, The Takeda Oncology Company, Novartis Pharmaceuticals Corporation, Pharmion Corporation, Wyeth; Speakers Bureau: GlaxoSmithKline, Millennium Pharmaceuticals, The Takeda Oncology Company. Dr VenookAdvisory Committee: Amgen Inc, ImClone Systems Incorporated; Grant Funding: Genentech BioOncology; Paid Research: Novartis Pharmaceuticals Corporation, Pfizer Inc.

RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS — The scientific staff and reviewers for Research To Practice have no real or apparent conflicts of interest to disclose.


This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors.

 

Editor
Neil Love, MD

Papers discussed by:
Dr Winer (Breast Cancer)

Dr Venook (Hepatocellular Carcionoma)

Dr George (Genitourinary Malignacies)

Dr Kim (Lung, Head & Neck and Thyroid Cancer)

Dr Leonard (Hematologic Malignancies)

Dr Venook (Colorectal Cancer)

Additional Publications Cited in the Program

A CME Audio Series and Activity

Faculty Disclosures

Editor's Office

Subscriptions

Media Center
Download PDF
Podcast
Previous Issues

 

Terms and Conditions of Use and General Disclaimer | Privacy Policy
Copyright © 2008 Research To Practice. All Rights Reserved.